share_log

Stephens & Co. Maintains Overweight on Avid Bioservices, Lowers Price Target to $12

Moomoo 24/7 ·  Mar 11 11:00

Stephens & Co. analyst Jacob Johnson maintains Avid Bioservices (NASDAQ:CDMO) with a Overweight and lowers the price target from $15 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment